Union

First Trust Dynamic Europe Equity Income Fund Issues Notice Regarding October 2021 Distribution

Retrieved on: 
Friday, October 15, 2021
Professional Services, Finance, Janus, Indian stock exchange, COVID-19, Internal Revenue Code, Fund, City, Risk, ERISA, Respiratory disease, Internal Revenue Code section 409A, FTA, Terrorism, Real estate investment trust, Fraud, NAV, Infection, NYSE, Disease, Notice, United Kingdom, Movement, REIT, Nature, Vaccine, Investment, Net asset value, European Union, Instability, FINRA, Judgement, AIB (NI), Calendar, Total return swap, Loss, FTP, Income, Union, Life insurance, Financial adviser, Financial services, Security (finance)

(2) The Fund estimates that it has distributed more than its income and net realized capital gains; therefore, a portion of your distribution may be a return of capital.

Key Points: 
  • (2) The Fund estimates that it has distributed more than its income and net realized capital gains; therefore, a portion of your distribution may be a return of capital.
  • A return of capital distribution does not necessarily reflect the Fund's investment performance and should not be confused with "yield" or "income."
  • The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.
  • First Trust Advisors L.P. ("FTA") is a federally registered investment advisor and serves as the Fund's investment advisor.

Amlan International to Showcase Health and Performance Benefits of Mineral-Based Feed Additives at Leman China Swine Conference

Retrieved on: 
Friday, October 15, 2021
Government, Diagnosis, Immune system, New, Growth, ODC, Marketing, Conference, NYSE, Disease, GLOBE, Â, European Union, Global Sales Law Project, Breeding, Amlan, Poultry, Safety, Patent, Livestock, Research, Genetics, NEC Corporation of America, Miniature pig, Animal, Union, Feed manufacturing

CHICAGO, Oct. 16, 2021 (GLOBE NEWSWIRE) -- At the upcoming 10th Leman China Swine Conference and 2021 World Swine Industry Expo, Amlan International will highlight how its natural, mineral-based feed additives are improving intestinal health in swine and helping producers overcome key economic production challenges.

Key Points: 
  • CHICAGO, Oct. 16, 2021 (GLOBE NEWSWIRE) -- At the upcoming 10th Leman China Swine Conference and 2021 World Swine Industry Expo, Amlan International will highlight how its natural, mineral-based feed additives are improving intestinal health in swine and helping producers overcome key economic production challenges.
  • As the animal health business of Oil-Dri Corporation of America, Amlan Internationals scientifically proven products are backed by Oil-Dris 80 years of experience in mineral science.
  • Swine producers in China are currently facing the lowest market price and highest price of feed ingredients theyve seen in the past five years, said Harold Zhou, Regional Operations Director of China.
  • This makes access to natural, antibiotic-free feed additives that can maintain swine health and improve performance while adding value even more important for producers.

Transaction in Own Shares

Retrieved on: 
Friday, October 15, 2021
Withdrawal, European Union (Withdrawal) Act 2018, European Union (Withdrawal Agreement) Act 2020, Market abuse, Royal Dutch Shell, Listing Rules, European Union, Company, Union, Animal, Online gambling

These share purchases form part of the Company's share buy-back arrangement previously announced on 29 July 2021.

Key Points: 
  • These share purchases form part of the Company's share buy-back arrangement previously announced on 29 July 2021.
  • In respect of this arrangement, Exane BNP Paribas will make trading decisions in relation to the Companys securities independently of the Company for a period from 29 July 2021 up to and including 29 December 2021.
  • In accordance with EU MAR and UK MAR, a full breakdown of the individual trades made by Exane BNP Paribas on behalf of the Company as a part of the buy-back arrangement is detailed below.
  • LEI number of Royal Dutch Shell plc: 21380068P1DRHMJ8KU70

JCP&L Welcomes Three New External Affairs Consultants

Retrieved on: 
Friday, October 15, 2021
Catholic higher education, Senate Democratic Caucus, FirstEnergy, View, Facebook, Senate, Virginia–Maryland College of Veterinary Medicine, New Jersey American Water, Industry, Seton Hall University School of Law, JCP, Dominion Energy, Widener University Delaware Law School, American Water Works, Government, Politics, Tinton Falls, New Jersey, New Jersey Department of Community Affairs, NYSE, Multimedia, Old Bridge, Environment, American Water, Earley, New Jersey Institute of Technology, Hampton University, Catholic University of America, New Jersey Senate, Water, Hunter College, Twitter, Association, Safety, Consultant, FE, Somerset County, Union, Central Powers, Public relations, Medicine

HOLMDEL, N.J., Oct. 15, 2021 /PRNewswire/ --Jersey Central Power and Light (JCP&L), a subsidiary of FirstEnergy Corp. (NYSE: FE), has named three new external affairs consultants to serve as liaisons with elected officials and to support local community involvement activities.

Key Points: 
  • HOLMDEL, N.J., Oct. 15, 2021 /PRNewswire/ --Jersey Central Power and Light (JCP&L), a subsidiary of FirstEnergy Corp. (NYSE: FE), has named three new external affairs consultants to serve as liaisons with elected officials and to support local community involvement activities.
  • "These new team members have extensive experience in engaging with their local communities and government officials," said James V. Fakult, president of Jersey Central Power & Light.
  • "Jarrell, Tina and Jolanta's involvement and ability to maintain strong relationships will provide lasting benefits for our customers and the communities we serve."
  • A Tinton Falls, New Jersey native, Coleman returns to his home state after most recently working in the supply chain department at Dominion Energy in Virginia.

KBRA Releases Report Assigning AA+ Rating to the City of Los Angeles’ General Obligation Bonds Series 2021-A and General Obligation Refunding Bonds Series 2021-B; Outlook is Stable

Retrieved on: 
Friday, October 15, 2021
Banking, Professional Services, Insurance, Finance, CRA, Ontario Securities Commission, Insurance commissioner, Credit, National Association of Insurance Commissioners, LLC, Société des Produits Nestlé S.A. v. Cadbury UK Limited, KBRA, European Securities and Markets Authority, National Association, European Union, U.S. Securities and Exchange Commission, ESG, Prospectus, Issuer, Union, Security (finance)

Kroll Bond Rating Agency, LLC (KBRA) is a full-service credit rating agency registered with the U.S. Securities and Exchange Commission as an NRSRO.

Key Points: 
  • Kroll Bond Rating Agency, LLC (KBRA) is a full-service credit rating agency registered with the U.S. Securities and Exchange Commission as an NRSRO.
  • Kroll Bond Rating Agency Europe Limited is registered as a CRA with the European Securities and Markets Authority.
  • Kroll Bond Rating Agency UK Limited is registered as a CRA with the UK Financial Conduct Authority pursuant to the Temporary Registration Regime.
  • KBRA is also recognized by the National Association of Insurance Commissioners as a Credit Rating Provider.

Merck and Eisai Receive Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Two Different Types of Cancer

Retrieved on: 
Friday, October 15, 2021
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, MSD, MRK, Royal commission, HIV disease progression rates, Death, Cancer, Risk, Radiation, RCC, Adult, European Medicines Agency, Advanced Therapy Medicinal Product, Committee, NYSE, Multimedia, PFS, Patient, Progression-free survival, European Union, European Commission, CHMP, EC, Committee for Medicinal Products for Human Use, Union, Pharmaceutical industry, LENVIMA® (lenvatinib); available as 10 mg and 4 mg capsules, Merck, Eisai, LENVIMA® (LENVATINIB); AVAILABLE AS 10 MG AND 4 MG CAPSULES, MERCK, EISAI

The safety and effectiveness of KEYTRUDA in pediatric patients with MSI-H central nervous system cancers have not been established.

Key Points: 
  • The safety and effectiveness of KEYTRUDA in pediatric patients with MSI-H central nervous system cancers have not been established.
  • KEYTRUDA is indicated for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib.
  • KEYTRUDA, in combination with LENVIMA, is indicated for the first-line treatment of adult patients with advanced RCC.
  • The safety and effectiveness of KEYTRUDA in pediatric patients with TMB-H central nervous system cancers have not been established.

AXIS Capital Provides Initial Comments on Third Quarter 2021 Results

Retrieved on: 
Thursday, October 14, 2021
Banking, Professional Services, Insurance, Finance, AXS, Government, Securities Exchange Act of 1934, Program, COVID-19, Industry, Social media, LinkedIn, Excellent, Security (finance), S&P Global Ratings, Securities Act of 1933, Insurance, SEC, Hurricane Ida, NYSE, AXIS Capital, United Kingdom, Contract, European Union, U.S. Securities and Exchange Commission, Forward-looking statement, Company, Annual report, EDT, Alert messaging, AXIS, Union, Reinsurance, Financial services, Risk management

AXIS Capital Holdings Limited ("AXIS Capital" or the "Company") (NYSE: AXS) today announced a third quarter net loss estimate for catastrophes and other weather-related events of approximately $250 million, pre-tax ($219 million, after-tax).

Key Points: 
  • AXIS Capital Holdings Limited ("AXIS Capital" or the "Company") (NYSE: AXS) today announced a third quarter net loss estimate for catastrophes and other weather-related events of approximately $250 million, pre-tax ($219 million, after-tax).
  • AXIS Capital also noted continuing improvements in its current accident year combined ratio excluding catastrophe and weather-related losses, consistent with progress observed in the first half of 2021.
  • The Company's results will be discussed during its conference call on Thursday, October 28, 2021 at 9:30 AM (EDT).
  • The Company uses its website ( www.axiscapital.com ) and its corporate LinkedIn (AXIS Capital) and Twitter (@AXIS_Capital) accounts as channels of distribution of Company information.

TILT Holdings Celebrates Brockton Medical Dispensary Grand Opening; Receives Final Adult-Use Retail Establishment License

Retrieved on: 
Thursday, October 14, 2021
Slate, VIP, Goal, Technology, Terminology, Projection, Golden Joystick Awards, NEO, Shinnecock Indian Nation, Swag, CAC, CCC, LLC, TILT, Commonwealth, Chroma, Patient, News, GLOBE, Phrase, Light, European Union, Company, CEO, Shinnecock, Research, Partnership, Timeline of cannabis laws in the United States, Toshiko Meets Her Old Pals, Union, Drug, Risk management

Additionally, the Massachusetts Cannabis Control Commission (CCC or the Commission) has awarded the CAC Brockton location a final adult-use retail establishment license, with sales to commence pending final inspection by the CCC.

Key Points: 
  • Additionally, the Massachusetts Cannabis Control Commission (CCC or the Commission) has awarded the CAC Brockton location a final adult-use retail establishment license, with sales to commence pending final inspection by the CCC.
  • We are proud to begin serving Brockton patients with premium product offerings in a welcoming and educational environment, said Gary Santo, CEO of TILT.
  • CACs Brockton dispensary is located at 1090 W. Chestnut Street and is open every day from 10 a.m. to 6 p.m.
  • TILT assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

Transaction in Own Shares

Retrieved on: 
Thursday, October 14, 2021
Withdrawal, European Union (Withdrawal) Act 2018, European Union (Withdrawal Agreement) Act 2020, Market abuse, Royal Dutch Shell, Listing Rules, European Union, Company, Union, Animal, Online gambling

These share purchases form part of the Company's share buy-back arrangement previously announced on 29 July 2021.

Key Points: 
  • These share purchases form part of the Company's share buy-back arrangement previously announced on 29 July 2021.
  • In respect of this arrangement, Exane BNP Paribas will make trading decisions in relation to the Companys securities independently of the Company for a period from 29 July 2021 up to and including 29 December 2021.
  • In accordance with EU MAR and UK MAR, a full breakdown of the individual trades made by Exane BNP Paribas on behalf of the Company as a part of the buy-back arrangement is detailed below.
  • LEI number of Royal Dutch Shell plc: 21380068P1DRHMJ8KU70

O'KEY Group S.A.: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Retrieved on: 
Thursday, October 14, 2021
CFO, European Parliament, ISO, Exercise, Council, Nature, UTC, Person, Directive 2014/65/EU, European, Union, Security (finance), Auction, Medical device, Online gambling, Reinsurance

For legal persons: full name including legal form as provided for in the register where it is incorporated, if applicable.

Key Points: 
  • For legal persons: full name including legal form as provided for in the register where it is incorporated, if applicable.
  • 2 For persons discharging managerial responsibilities: the position occupied within the issuer, emission allowances market participant/auction platform/auctioneer/auction monitor should be indicated, e.g.
  • - Name and position of the relevant person discharging managerial responsibilities.
  • 3 Indication that this is an initial notification or an amendment to prior notifications.